Literature DB >> 15717149

Computerized three-dimensional potential mapping with a multielectrode basket catheter can be useful for pulmonary vein electrical disconnection.

Takumi Yamada1, Yoshimasa Murakami, Masahiro Muto, Taro Okada, Mitsuhiro Okamoto, Takeshi Shimizu, Junji Toyama, Yukihiko Yoshida, Naoya Tsuboi, Teruo Ito, Takahisa Kondo, Yasuya Inden, Makoto Hirai, Toyoaki Murohara.   

Abstract

INTRODUCTION: Pulmonary vein (PV) isolation (PVI) has been recently proposed as an effective technique to cure atrial fibrillation (AF). AIMS OF THE STUDY: The aim of this study was to investigate the efficacy of a novel technique utilizing a computerized three-dimensional mapping system (QMS2) with a multielectrode basket catheter (MBC) for PVI and to reveal the relation between the style of breakthrough and the network of the PV musculature.
METHODS: Sixty-five consecutive patients with frequent AF attacks underwent PV mapping with a 31-mm MBC, and a three-dimensional color animation of the potential map was constructed by the QMS2. The animation color schema was arranged to minimize the low-amplitude left atrial (LA) potentials and emphasize the high-amplitude PV potentials (PVPs). The longitudinal PVP map enabled us to recognize the true breakthroughs and reveal the network of the PV musculature.
RESULTS: A total of 205 PVs (65 left superior PVs, 65 right superior PVs, 57 left inferior PVs and 18 right inferior PVs) were mapped and successful PVI was achieved in all PVs, except one that had no PVPs, with a mean radiofrequency duration of 7 +/- 5 minutes per PV. In about 90% of the PVs, a final radiofrequency application eliminated all the distal PVPs simultaneously because the PVI was performed at the appropriate LA-PV junction. A single segmental breakthrough was detected in 17 PVs, single broad breakthrough in 83 PVs, multiple separate breakthroughs with a distal connection between the PV musculatures extending from each separate breakthrough in 88 PVs and multiple separate breakthroughs without that connection in 16 PVs. During the follow-up period, fifty-one (78%) patients were free of symptomatic AF without any antiarrhythmic drugs after multiple procedures (thirty-three (51%) of those patients after the first procedure) and no PV stenosis was found.
CONCLUSIONS: Computerized three-dimensional potential mapping can be useful for PVI because it can not only identify the true breakthrough, but can also confirm the elimination of the breakthroughs by the change in the activation sequence through the network of the PV musculature.

Entities:  

Mesh:

Year:  2005        PMID: 15717149     DOI: 10.1007/s10840-005-5838-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  12 in total

1.  Pulmonary vein occlusion/stenosis after pulmonary vein ablation for atrial fibrillation.

Authors:  Hakan Oral
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04

2.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation.

Authors:  S A Chen; M H Hsieh; C T Tai; C F Tsai; V S Prakash; W C Yu; T L Hsu; Y A Ding; M S Chang
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

3.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

4.  Elimination of focal atrial fibrillation with a single radiofrequency ablation: use of a basket catheter in a pulmonary vein for computerized activation sequence mapping.

Authors:  J Michael Mangrum; D E Haines; J P DiMarco; J Paul Mounsey
Journal:  J Cardiovasc Electrophysiol       Date:  2000-10

5.  The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts.

Authors:  H Nathan; M Eliakim
Journal:  Circulation       Date:  1966-09       Impact factor: 29.690

6.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

7.  Left atrial myocardial extension onto pulmonary veins in humans: anatomic observations relevant for atrial arrhythmias.

Authors:  T Saito; K Waki; A E Becker
Journal:  J Cardiovasc Electrophysiol       Date:  2000-08

8.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

9.  Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies.

Authors:  Nassir F Marrouche; Thomas Dresing; Christopher Cole; Dianna Bash; Eduardo Saad; Krzysztof Balaban; Stephen V Pavia; Robert Schweikert; Walid Saliba; Ahmed Abdul-Karim; Ennio Pisano; Raffaele Fanelli; Patrick Tchou; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

10.  Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation.

Authors:  Atsushi Takahashi; Yoshito Iesaka; Yoshihide Takahashi; Ryoko Takahashi; Kenzaburo Kobayashi; Katsumasa Takagi; Osamu Kuboyama; Takeo Nishimori; Hidenobu Takei; Hiroshi Amemiya; Hideomi Fujiwara; Masayasu Hiraoka
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

View more
  1 in total

1.  Pulmonary vein isolation with a multielectrode basket catheter.

Authors:  Takumi Yamada
Journal:  Indian Pacing Electrophysiol J       Date:  2007-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.